August 26, 2013 at 12:00 pm
Austin FraktThe July issue of Health Affairs included a systematic review of observational studies of value-based insurance design for prescription drugs. I summarized it in a post on the AcademyHealth blog, which I failed to notice came out in mid-August. So, in case you missed it — as I did — go read!
Comments closed
by Tony Nefouse on August 26th, 2013 at 15:05
The insurance community is currently building group health plans that follow these guidelines. It’s just a matter of time before medical facilities will have to justify their pricing and outcomes to be a part of PPO networks.